Aravive, Inc.

Aravive, Inc.verified

ARAV

Price:

$0.0401

Market Cap:

$2.95M

Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics (Hong K...[Read more]

Industry

Biotechnology

IPO Date

2014-03-21

Stock Exchange

NASDAQ

Ticker

ARAV

The Enterprise Value as of November 2024 (TTM) for Aravive, Inc. (ARAV) is -3158140.00

According to Aravive, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -3158140.00. This represents a change of -104.70% compared to the average of 67.19M of the last 4 quarters.

Aravive, Inc. (ARAV) Historical Enterprise Value (quarterly & annually)

How has ARAV Enterprise Value performed in the past?

The mean historical Enterprise Value of Aravive, Inc. over the last ten years is 151.51M. The current -3158140.00 Enterprise Value has changed -308.45% with respect to the historical average. Over the past ten years (40 quarters), ARAV's Enterprise Value was at its highest in in the March 2017 quarter at 590.43M. The Enterprise Value was at its lowest in in the March 2014 quarter at -121142539.90.

Quarterly (TTM)
Annual

Average

151.51M

Median

70.28M

Minimum

-24426080.00

Maximum

717.09M

Aravive, Inc. (ARAV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aravive, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.24%

Maximum Annual Enterprise Value = 717.09M

Minimum Annual Increase = -1469.36%

Minimum Annual Enterprise Value = -24426080.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022594.04K-106.53%
2021-9097700.00-124.57%
202037.03M-64.23%
2019103.52M-523.82%
2018-24426080.00-1469.36%
20171.78M-99.31%
2016257.53M45.67%
2015176.80M-30.46%
2014254.23M-64.55%
2013717.09M2.24%

Aravive, Inc. (ARAV) Average Enterprise Value

How has ARAV Enterprise Value performed in the past?

The current Enterprise Value of Aravive, Inc. (ARAV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

9.51M

5-year avg

21.52M

10-year avg

151.51M

Aravive, Inc. (ARAV) Enterprise Value vs. Peers

How is ARAV’s Enterprise Value compared to its peers?

Aravive, Inc.’s Enterprise Value is greater than Magenta Therapeutics, Inc. (-114170976.00), less than ASLAN Pharmaceuticals Limited (9.97M), greater than AVROBIO, Inc. (-85302404.00), greater than Aeglea BioTherapeutics, Inc. (-41964351.00), less than Autolus Therapeutics plc (470.32M),

CompanyEnterprise ValueMarket cap
-114170976.00$42.44M
9.97M$1.70M
-85302404.00$5.24M
-41964351.00$48.63M
470.32M$888.59M

Build a custom stock screener for Aravive, Inc. (ARAV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aravive, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aravive, Inc. (ARAV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aravive, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Aravive, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Aravive, Inc. (ARAV)?

What is the 3-year average Enterprise Value for Aravive, Inc. (ARAV)?

What is the 5-year average Enterprise Value for Aravive, Inc. (ARAV)?

How does the current Enterprise Value for Aravive, Inc. (ARAV) compare to its historical average?